By Abigail Summerville
NEW YORK, Dec 20 (Reuters) - Private equity firm L
Catterton has appointed former Vitamin Shoppe CEO Colin Watts as
Thorne HealthTech's next leader following its $680 million
acquisition of the U.S. health and wellness company in October.
Thorne told Reuters on Wednesday that Watts will succeed
outgoing CEO Paul Jacobson, who will lead a new business called
Thorne Ventures that researches and develops scientific wellness
breakthroughs.
Thorne provides at-home health tests and supplements for
sleep, fertility, stress, gut health and more. Thorne Ventures
will aim to identify the next generation of products and
services in the wellness space. They will operate as two
separate units that will have a high degree of collaboration.
Watts, who led Vitamin Shoppe between 2015 and 2018, also
previously served as president of Weight Watchers Health
Solutions, chief innovation officer at Walgreens, and global
operating president of McNeil Nutritionals and Consumer
Healthcare, a division of Johnson & Johnson.
Paul Jacobson, a Thorne co-founder, has also served on its
board of directors since 2010. He also co-founded Onegevity
Health, LLC, which became a division of Thorne in 2021.
Thorne's current Chief Operating Officer Tom McKenna, who
has been with the company for 14 years, will continue in his
role.
Thorne has more than five million customers, including
thousands of professional athletes, over 100 professional sports
teams, and multiple U.S. National Teams.
(Reporting by Abigail Summerville; editing by Diane Craft)
((abigail.summerville@thomsonreuters.com;))